PPIL4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.90489973689512E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.50320000014537E-07 |
Normal-vs-Stage2 |
3.846300E-04 |
Normal-vs-Stage3 |
1.45419998265339E-09 |
Normal-vs-Stage4 |
1.85699999821765E-09 |
Stage1-vs-Stage2 |
4.799200E-01 |
Stage1-vs-Stage3 |
8.418700E-03 |
Stage1-vs-Stage4 |
1.927960E-02 |
Stage2-vs-Stage3 |
5.485400E-01 |
Stage2-vs-Stage4 |
4.673600E-01 |
Stage3-vs-Stage4 |
7.927000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.00599995001005E-09 |
Normal-vs-AfricanAmerican |
9.7766999995752E-07 |
Normal-vs-Asian |
3.400800E-01 |
Caucasian-vs-AfricanAmerican |
4.283000E-01 |
Caucasian-vs-Asian |
2.516600E-01 |
AfricanAmerican-vs-Asian |
1.560780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.22060037025074E-10 |
Normal-vs-Female |
4.78050000030095E-07 |
Male-vs-Female |
1.040820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.176000E-04 |
Normal-vs-Age(41-60Yrs) |
4.07120000045502E-07 |
Normal-vs-Age(61-80Yrs) |
1.99529948119448E-10 |
Normal-vs-Age(81-100Yrs) |
1.9479399999911E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.914000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.865000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.761200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.918400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.366770E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.335010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.232000E-01 |
Normal-vs-Grade 2 |
2.194500E-04 |
Normal-vs-Grade 3 |
4.4881987015799E-11 |
Normal-vs-Grade 4 |
1.33249999922924E-09 |
Grade 1-vs-Grade 2 |
1.737020E-01 |
Grade 1-vs-Grade 3 |
1.170950E-04 |
Grade 1-vs-Grade 4 |
1.199070E-03 |
Grade 2-vs-Grade 3 |
4.03120000003199E-06 |
Grade 2-vs-Grade 4 |
4.627000E-04 |
Grade 3-vs-Grade 4 |
6.868200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.742220E-03 |
Normal-vs-ccB subtype |
4.36117808533254E-12 |
ccA subtype-vs-ccB subtype |
4.06039999956143E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.96060000246368E-08 |
Normal-vs-N1 |
5.74089999999527E-05 |
N0-vs-N1 |
7.395800E-02 |
|
|